Scholarlink

Background <p>The recent emergence of artemisinin resistance in Africa is drawing scrutiny toward the use of alternative anti-malarial therapy based on <i>Artemisia annua</i> and <i>Artemisia afra</i> phytotherapies. This study aimed to determine if either <i>A. annua</i> and <i>A. afra</i> extracts are active against artemisinin-resistant <i>Plasmodium falciparum</i> isolates and determine the selectivity of inhibitory phytotherapies.</p> Methods <p><i>Artemisia</i> extracts were tested in vitro to mimic parasites exposure to extracts in population drinking <i>Artemisia</i> sp<i>.</i> teas. <i>Artemisia</i> extracts were tested in Ring Stage Survival Assays (RSA<sup>0−3 h</sup>) against Cambodian clinical isolates previously genetically and phenotypically characterized as artemisinin resistant or sensitive. Primary human hepatocytes and a human hepatoblastoma cell line (HepG2 cells) were used to assess the cytotoxicity of <i>Artemisia</i> extracts.</p> Results <p>The study revealed a substantially decreased in vitro activity of <i>A. annua</i> extracts when tested on artemisinin-resistant parasites mutated in the <i>Pfkelch13</i> gene (RSA<sub>50</sub> 0.137–2.56&#xa0;g.L<sup>−1</sup>) compared to artemisinin-sensitive parasites (RSA<sub>50</sub> 0.080&#xa0;g.L<sup>−1</sup>). Conversely, the <i>A. afra</i> extracts have a similar activity on the isolates tested whether they are sensitive or resistant to artemisinin (RSA<sub>50</sub> 0.537–0.758&#xa0;g.L<sup>−1</sup>) However, the selectivity index for <i>A. afra</i> extracts was much lower than for <i>A. annua</i> extracts (<i>A. afra:</i> 4.628, 4.305 and 6.076 vs <i>A. annua:</i> 387.625, 226.350 and 12.099, respectively for WT, C580Y and R539T).</p> Conclusions <p><i>Artemisia annua</i> activity is driven by artemisinin, implicating the same resistance profiles and concerns associated with semisynthetic artemisinin derivatives. <i>Artemisia afra</i> showed artemisinin-independent antiplasmodial activity. However, the molecular basis of this activity is unknown and may not present a sufficient selectivity, thus further characterization of <i>A. afra</i> is essential.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of the in vitro activity and selectivity of Artemisia afra and Artemisia annua aqueous extracts against artemisinin-resistant Plasmodium falciparum

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月11日

查看全文
  • Camille Roesch,
  • Kutub Ashraf,
  • Amélie Vantaux,
  • Adriana A. Marin,
  • Steven P. Maher,
  • Jean-Francois Franetich,
  • Nimol Kloeung,
  • Sopheakvatey Ke,
  • Hoa Thi My Vo,
  • Jean-Christophe Barale,
  • Dominique Mazier,
  • Benoit Witkowski

摘要

Background

The recent emergence of artemisinin resistance in Africa is drawing scrutiny toward the use of alternative anti-malarial therapy based on Artemisia annua and Artemisia afra phytotherapies. This study aimed to determine if either A. annua and A. afra extracts are active against artemisinin-resistant Plasmodium falciparum isolates and determine the selectivity of inhibitory phytotherapies.

Methods

Artemisia extracts were tested in vitro to mimic parasites exposure to extracts in population drinking Artemisia sp. teas. Artemisia extracts were tested in Ring Stage Survival Assays (RSA0−3 h) against Cambodian clinical isolates previously genetically and phenotypically characterized as artemisinin resistant or sensitive. Primary human hepatocytes and a human hepatoblastoma cell line (HepG2 cells) were used to assess the cytotoxicity of Artemisia extracts.

Results

The study revealed a substantially decreased in vitro activity of A. annua extracts when tested on artemisinin-resistant parasites mutated in the Pfkelch13 gene (RSA50 0.137–2.56 g.L−1) compared to artemisinin-sensitive parasites (RSA50 0.080 g.L−1). Conversely, the A. afra extracts have a similar activity on the isolates tested whether they are sensitive or resistant to artemisinin (RSA50 0.537–0.758 g.L−1) However, the selectivity index for A. afra extracts was much lower than for A. annua extracts (A. afra: 4.628, 4.305 and 6.076 vs A. annua: 387.625, 226.350 and 12.099, respectively for WT, C580Y and R539T).

Conclusions

Artemisia annua activity is driven by artemisinin, implicating the same resistance profiles and concerns associated with semisynthetic artemisinin derivatives. Artemisia afra showed artemisinin-independent antiplasmodial activity. However, the molecular basis of this activity is unknown and may not present a sufficient selectivity, thus further characterization of A. afra is essential.